Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review

Background: Immune checkpoint inhibitors (ICI) have represented a revolution in the treatment of non-small-cell lung cancer (NSCLC). To improve these results, combined approaches are being tested. The addition of stereotactic ablative radiotherapy (SABR) to ICI seems promising. A systematic review w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Mol Sci
Autors principals: Chicas-Sett, Rodolfo, Morales-Orue, Ignacio, Castilla-Martinez, Juan, Zafra-Martin, Juan, Kannemann, Andrea, Blanco, Jesus, Lloret, Marta, Lara, Pedro C
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6540197/
https://ncbi.nlm.nih.gov/pubmed/31052488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20092173
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars